Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05451225 · ClinicalTrials.gov registry record · NA
Survey of Correction Officers Before and After a Targeted Education Campaign
A NA study of Work-Related Condition, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 451
- Enrollment target
- 1
- Study location
NCT05451225: Completed NA study of Work-Related Condition, sponsored by Columbia University.
NCT05451225 is a NA study of Work-Related Condition that has completed, run by Columbia University. The registered enrollment target is 451 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05451225, a NA study of Work-Related Condition, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 451 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will implement a multifaceted Target Education Campaign (TEC) within the three jails about recognizing early psychotic symptoms and referring to the Correctional Health Services. This campaign will include print materials and targeted trainings for Correction Officers. To develop all aspects of the TEC, the investigators will convene a workgroup, meeting biweekly for the first 6 months, including the entire investigative team, as well as experts at the Center for Practice Innovations (CPI). Depending on the nature of agreed-upon educational materials, the investigators will use specific areas of expertise at CPI for development. Materials will provide specific, actionable, and persuasive messaging about: (1) how to identify select signs of psychosis, (2) how to refer to the Specialized Early Engagement Support Service (SEESS) (in year 2), and (3) the effectiveness of early treatment through coordinated specialty care for early psychosis. Messaging will be continuous in the three jails.
Primary Outcome
Survey-based scores on knowledge/skills at baseline. To measure behavioral capability (knowledge/skills), the investigators used the Correction Officers' Behavioral Capability Scale, which has a minimum value of 0 and maximum value of 10. Higher scores mean better knowledge about psychosis and therefore a better outcome.
Conditions Studied
Interventions
- BEHAVIORAL Targeted Educational Campaign
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2020-01-08 |
| Est. Completion | 2022-03-05 |
| Phase | NA |
What the finished NCT05451225 record still lists
NCT05451225 is an interventional study that assigns participants to a tested intervention. The registered 451 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Work-Related Condition appearing as the primary indexed condition, and to 1 intervention - of which Targeted Educational Campaign is the first listed.
NCT05451225 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05451225 about?
NCT05451225 is a clinical study titled "Survey of Correction Officers Before and After a Targeted Education Campaign". The investigators will implement a multifaceted Target Education Campaign (TEC) within the three jails about recognizing early psychotic symptoms and referring to the Correctional Health Services. This campaign will include print materials and targeted trainings for Correction Officers. To develop a...
What is the current status of trial NCT05451225?
This trial is currently completed. It is a NA study. The enrollment target is 451 participants. The study started on 2020-01-08. Estimated completion is 2022-03-05.
What conditions does trial NCT05451225 study?
This clinical trial studies the following conditions: Work-Related Condition.
What interventions are being tested in trial NCT05451225?
The interventions under investigation include: Targeted Educational Campaign (BEHAVIORAL).
Who is sponsoring clinical trial NCT05451225?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05451225 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Work-Related Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05451225's enrollment target sits among peer trials
451 225th of 2000 higher than 1,776 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI